Rudi Boyd

Rudi's page

Fundraising for Cure Leukaemia
£2,075
raised of £1,500 target
Donations cannot currently be made to this page
Event: London 2 Paris 2023, from 8 June 2023 to 12 June 2023
Participants: Jamie Menzies, Kirk Gill, Brett Wiggins & Daniel Stafford
2023 London 2 Paris
Campaign by Cure Leukaemia (RCN 1100154)
Cure Leukaemia's London 2 Paris returns in 2023 for another fantastic 4-days of cycling, and this year is set to be our biggest year EVER and is an incredible experience!

Story

As a novice rider and given the opportunity to help raise funds for the cause I couldn't say No!

Cure Leukaemia helps blood cancer patients to access pioneering drug and transplant treatments by funding a network of specialist research nurses across the UK. Without these nurses, to ensure patients are monitored and cared for, clinical trials of these new treatments would not run and patients, that have exhausted standard treatment options, would miss out on potentially lifesaving therapies. Every penny raised for Cure Leukaemia helps save lives and also hastens global progress towards the eradication of all forms of blood cancer.

Share this story

Help Rudi Boyd

Sharing this page with your friends could help raise up to 3x more in donations

You can also help by sharing this link on

About the campaign

Cure Leukaemia's London 2 Paris returns in 2023 for another fantastic 4-days of cycling, and this year is set to be our biggest year EVER and is an incredible experience!

About the charity

Cure Leukaemia

Verified by JustGiving

RCN 1100154
Cure Leukaemia fund research nurses at 15 hospitals across the UK. These roles form the Trials Acceleration Programme (TAP) network giving patients, from a catchment area of 30m, access to potentially life-saving treatments through clinical trials, with plans to fund a paediatric network on the way.

Donation summary

Total raised
£2,075.00
Online donations
£2,075.00
Offline donations
£0.00

* Charities pay a small fee for our service. Find out how much it is and what we do for it.